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ABSTRACT 
The 5’ cap structure  (m7GpppX-) is an essential feature of eukaryotic mRNA required for 
mRNA stability and efficient translation. Influenza virus furnishes its mRNA with this 
structure by a cap-snatching mechanism, in which the viral polymerase cleaves host mRNA 
endonucleolytically 10-13 nucleotides from the 5’ end, and utilizes the capped fragment as 
a primer to synthesize viral transcripts. Here we report a novel cap-snatching mechanism by 
which the yeast double-stranded RNA totivirus L-A furnishes its transcript with a cap 
structure derived from mRNA. Unlike influenza virus, L-A transfers only m7Gp from the 
cap donor to the 5’ end of the viral transcript, thus preserving the 5’ α- and β-phosphates of 
the transcript in the triphosphate linkage of the final product. This in vitro capping reaction 
requires His154 of the coat protein Gag, a residue essential for decapping of host mRNA 
and known to form m7Gp-His adduct. Furthermore, the synthesis of capped viral transcripts 
in vivo and their expression were greatly compromised by the Arg154 mutation, indicating 
the involvement of Gag in the cap-snatching reaction.  The overall reaction and the 
structure around the catalytic site in Gag resemble those of guanylyltransferase, a key 
enzyme of cellular mRNA capping, suggesting convergent evolution. Given that Pol of L-A 
is confined inside the virion and unable to access host mRNA in the cytoplasm, the 
structural protein Gag rather than Pol catalyzing this novel cap-snatching reaction 
exemplifies the versatility as well as the adaptability of eukaryotic RNA viruses.  
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/body Eukaryotic mRNA is capped at the 5’ end by a 7-methyl GMP moiety via an 
inverted 5’-5’ triphosphate linkage (m7GpppX) (1, 2). The cap structure is required for 
mRNA stability and efficient translation. Capping of RNA 5’ end is accomplished in cells 
and for most viruses in three sequential catalytic reactions (3, 4): removal of the 5’ γ-
phosphate by RNA triphosphatase, addition of GMP from GTP by guanylyltransferase and 
methylation of the added GMP by methyltransferase. Influenza virus, however, employs a 
different mechanism (cap-snatching) to furnish its mRNA with the structure (5-7). The 
trimeric viral polymerase binds the cap of host mRNA, cleaves the RNA 
endonucleolytically 10-13 nucleotides downstream and utilizes the capped fragment as a 
primer to synthesize its transcript. So far, only negative stranded RNA viruses and 
ambiviruses (the Orthomyxoviridae, Bunyaviridae, and Arenaviridae families) have been 
known to use this strategy to furnish their mRNAs.  
The totivirus L-A, which infects the yeast Saccharomyces cerevisiae, has a non-
segmented double-stranded RNA (dsRNA) genome of 4.6 kilobases (kb) (8). Typical of 
fungal viruses, L-A has no extracellular transmission pathway. This virus is transmitted 
vertically from mother to daughter cells, or horizontally through mating. The L-A genome 
contains two overlapping genes, gag and pol, and the latter is expressed as a Gag-Pol fusion 
protein by a -1 ribosomal frameshift (9, 10). The genome is packed inside of a 39 nm 
icosahedral capsid consisting of 60 asymmetric Gag dimers, in which one or two Gag 
molecules are substituted by Gag-Pol. The N terminal Pol region is necessary for genome 
packaging, although Gag alone is sufficient to form morphologically normal capsids (11). 
M1, a satellite RNA of L-A, has a dsRNA genome (1.6-1.8 kb) that encodes a protein toxin 
and immunity (12) but no protein necessary for its own replication. It requires L-A for 
encapsidation and replication. Thus M1 can be maintained in the cell without the helper 
virus provided that L-A proteins are expressed from a vector (13). Two decades ago Blanc 
et al. (14) found that the L-A coat protein Gag covalently binds the cap structure of mRNA. 
The reaction was inhibited by the cap analogue m7GpppG but not by the non-methylated 
GpppG.  The subsequent study revealed that m7Gp decapped from mRNA covalently 
attached to His154 of Gag (15). Site-directed mutagenesis found His154 essential for 
decapping of mRNA but its mutation (Arg154) did not affect transcription, replication and 
encapsidation of viral RNA (15). L-A virions can synthesize positive strand transcripts in 
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vitro in a conservative manner (16). Recently we found that L-A and M1 transcripts have 
diphosphate at their 5’ termini (5’-ppGAAAAAU…; L-A and M1 share the same 7-nt 
sequences at the 5’ ends) (17). More strikingly, when transcription was primed with GTP or 
GMP, the transcripts again bore the diphosphate at the 5’ ends. In the latter case, the 5’ β-
phosphate was derived from the γ-phosphate of ATP present in the reaction. Therefore, L-A 
virus deliberately keeps its transcripts diphosphorylated at the 5’ ends.  
We speculated that, if m7Gp derived from host mRNA was transferred to the 
diphosphorylated 5’ end of the viral transcript, it would produce an authentic cap structure 
in yeast. We tested this hypothesis. Here we describe a novel cap-snatching mechanism in 
the dsRNA virus L-A. L-A only transfers the m7Gp moiety derived from mRNA to its 
transcript. We also demonstrate that this capping reaction is essential for efficient 
expression of the viral transcript.  
 
RESULTS 
Cap transfer reaction. A 5 nt cap donor, 32p-labeled at the γ-phosphate of the triphosphate 
linkage, was incubated with L-A virions in a transcription mixture containing the 4 NTPs. 
The full-length L-A transcript incorporated the radioactivity (Fig. 1A, lane 1). To further 
analyze the reaction, CTP was omitted and GTP was replaced by GDP. Previously we 
observed that GDP is a better substrate to prime transcription than GTP (17). Because the 
first C appears at position 17 in the L-A transcript, the virions synthesize a 16 nt L-A 
fragment in the absence of CTP. L-A virions can also incorporate a cap analogue 
(m7GpppG) as a primer and produced a 17-nt transcript (17). In the presence of the cap 
donor, GDP-primed transcripts incorporated the label, which moved in a polyacrylamide 
gel slightly slower than the 16 nt transcript but as fast as a cap analogue (m7GpppG)-
primed 17 nt transcript did (Fig. 1B, lanes 4 to 6). The omission of GDP abrogated the 
incorporation, indicating that the reaction is transcription-dependent and that the cap donor 
(or part of it) was not used as a primer (Fig. 1B, lane 3). The labeled product was isolated 
from the gel and analyzed by thin layer chromatography (TLC). Bacterial alkaline 
phosphatase (BAP) treatment did not release radioactivity (Fig. 1C, lane 7), indicating that 
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the product was internally labeled. Nuclease S1 treatment digested the RNA body but could 
not work on the triphosphate linkage, thus releasing the labeled cap analogue (m7GpppG) 
(Fig. 1C, lane 5). Tobacco acid pyrophosphatase (TAP) treatment released labeled m7Gp 
(Fig. 1C, lane 6). Because TAP can hydrolyze anhydrous bonds between α− and β−, and 
also β− and γ−phosphates of the triphosphate linkage, it indicates that the label was located 
at the γ−phosphate in the capped product. These results demonstrate that, at least, the m7Gp 
moiety of the cap donor was transferred to the 5’ end of the viral transcript and formed a 
new cap structure on it.  The reaction required a high concentration of PEG 4000 (Fig. S1) 
while a non-methylated capped molecule made in the absence of SAM did not function as 
cap donor (Fig. 1D, lane 4). PEG is known to have bulk structure in aqueous solution that 
causes crowding of macromolecules in the solution and has successfully been used to 
reconstitute the transcriptase activity of L-A virus in vitro (18). A 107 nt capped molecule 
exhibited similar or better donor activity than the 5 nt donor (Fig. S2). 
 
Preservation of the 5’ α−  and β−phosphates of the viral transcripts in the 
triphosphate linkage during cap transfer. The gel mobility of the capped transcript (Fig. 
1B) strongly suggests that only the m7Gp moiety of the cap donor was transferred to the 5’ 
end of the viral transcript. Here we confirm this. We found that the cap analogue m7GpppG 
but not GpppG could be used as cap donor and produced the 17 nt-capped product (Fig. 
2A). This allowed us to specifically label the 5’ end of the viral transcript (acceptor) and 
examine its fate during cap transfer. In the absence of CTP, L-A virion incorporates [α-32P] 
GTP at the 5’ end of the 16 nt transcript with the label located at the α position.  In the 
presence of m7GpppG, part of transcripts (ca. 20%) was converted to a BAP-resistant 17-
mer (Fig. 2A, lane 4). This species was gel-purified and analyzed by TLC. S1 treatment 
released m7GpppG, thus confirming the formation of cap structure at the 5’ end (Fig. 2B, 
lane 5). By contrast the 16-nt transcript released GDP upon S1 digestion (Fig. 2B, lane 2) 
as observed previously (17). After TAP treatment the capped product remained at the origin 
(Fig. 2B, lane 6), indicating that the label was still associated with the RNA body of 16 nt. 
A further treatment with S1, however, converted it to GMP (Fig. 2B, lane 7). These results 
indicate that during cap transfer the α-phosphate at the 5’ end of the acceptor is preserved 
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at the α-position in the triphosphate linkage of the capped product. When transcription is 
primed with GMP, the virion adds the β-phosphate at the 5’ end of the transcript at the 
expense of ATP (17).  Thus the 5’ β-phosphate of the acceptor can be labeled specifically 
with [γ-32P] ATP, as shown in Fig. 2D. S1 treatment released GDP (Fig. 2D, lane 2), 
indicating that the 16-nt transcript had diphosphate at the 5’ end. Furthermore, the 
transcript released labeled Pi upon RNA 5’ polyphosphatase (RPP) treatment (Fig. 2D, lane 
3). Because the enzyme does not work on the 5’ α-phosphate, it indicates that the label was 
located at the 5’ β-phosphate in the transcript. In the presence of m7GpppG, part of 16-mer 
again was converted to a BAP-resistant 17-mer (Fig. 2C, lane 5).  The formation of cap 
structure at the 5’ end of the 17-mer was confirmed by S1 digestion (Fig. 2D, lane 6). This 
time, however, the 17-mer produced labeled Pi upon TAP treatment (Fig. 2D, lane 7), thus 
confirming that the marker was located at the β-position of the triphosphate linkage in the 
cap structure. These results altogether depict L-A virus’ cap-snatching mechanism distinct 
from that of influenza virus: L-A virus transfers only m7Gp from mRNA to the 
diphosphorylated 5’ terminus of its transcript. In addition, while influenza virus requires a 
capped mRNA fragment as a primer for transcription (19), L-A virus can synthesize its 
transcript in the absence of cap transfer.  
 
Involvement of Gag in the cap-snatching reaction. M1 requires L-A for encapsidation 
and replication. M1 can be maintained in the cell in the absence of the helper virus 
provided L-A proteins are expressed from a vector (13). Like L-A, M1 virions formed with 
wild type L-A proteins have decapping activity and formed m7Gp-Gag adduct when 
incubated with the 5-nt cap donor (Fig. 3A, lanes 1 and 2). By contrast, M1 virions formed 
with a mutant Gag (Arg154) failed to form the adduct as demonstrated previously (15) (Fig. 
3A, lane 3). This mutant Gag can support M1, therefore transcription, encapsidation and 
replication of M1 are not impaired by the mutation. When M1 virions were incubated in a 
transcription mixture with the 5-nt cap donor, the virions with the wild type L-A proteins 
transferred m7Gp from the donor to the transcript (Fig. 1A, lane 2), whereas the virions 
with the mutant Gag failed to do so (Fig. 1A, lane 3). Because mutant M1 virions 
synthesized transcripts with 5’ diphosphate (Fig. S3) as wild type virions did (17), these 
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results indicate that the Arg154 mutation specifically impaired the cap-snatching reaction, 
thus signifying the involvement of the decapping reaction in cap-snatching.     
 
Cap-snatching is essential for efficient expression of viral transcripts. We have 
demonstrated that L-A and M1 virions can synthesize capped transcripts in vitro. However, 
capped viral transcripts in vivo have not been detected yet. We tried to prove their existence 
in the cell. RNA was extracted from cells containing M1 virions with wild type or Arg154 
mutant Gag protein. Capped RNA was then isolated using a monoclonal anti-cap antibody. 
As shown in Fig. 3B, lane 1, we could detect capped M1 transcripts from virions with wild 
type L-A protein, while capped RNA from M1 virions with mutant Gag was barely 
detectable. Because M1 in these strains was supported by plasmid-encoded L-A proteins, 
capped L-A RNA transcribed by PolII was used as a positive control. There was no 
difference in the amount of capped L-A RNA between these strains (Fig. 3B, lane 4). The 
results therefore demonstrate that the Gag mutation Arg154 specifically affects capping of 
virion-derived transcripts. The strain carrying M1 with wild type L-A proteins produces 
protein toxin and kills sensitive cells.  By contrast the strain harboring the mutant Gag 
barely produces the toxin as described (15) (Fig. 3C). From these in vivo results we 
conclude that the cap-snatching mechanism operates in the cell and does produce capped 
viral transcripts, and that the capping reaction is essential for efficient expression of the 
viral genome.  
 
DISCUSSION 
We have demonstrated a novel mechanism of cap-snatching in the yeast dsRNA 
virus L-A. The virus transfers the m7Gp moiety from host mRNA to the diphosphorylated 
5’ end of viral transcript, thus generating an authentic cap structure (referred to as cap0) in 
the budding yeast. The mechanism is distinct from that of influenza virus. Influenza virus 
endonucleolytically cleaves host mRNA 10-13 nt downstream from the 5’ end and utilizes 
the resulting capped oligo fragment as a primer to synthesize its transcript. The L-A cap-
snatching mechanism is essential for efficient expression of viral transcripts and strikingly, 
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His154 of Gag is involved in this process. In influenza virus the trimeric polymerase 
performs cap-snatching. It is surprising to find a novel cap-snatching activity in the 
structural coat protein Gag. However, considering that the Pol domain of the Gag-Pol 
fusion protein is confined inside the virion and unable to access mRNA in the cytoplasm, it 
is quite reasonable that Gag but not Pol performs the reaction. Thus these findings 
exemplify the versatility and adaptability of eukaryotic RNA viruses.  
The cap-snatching reaction of L-A virus requires a high concentration of PEG 4000 
and 7-methylation of cap is essential for cap-donor activity. Interestingly L-A virions used 
m7GpppG in vitro as a cap donor. Thus the virus can potentially utilize not only host 
mRNA but also m7GpppG or capped oligo fragments generated from the 3’-5’ mRNA 
degradation pathway carried out by the exosome (20, 21), as cap donors. A substantial 
amount (ca. 20%) of transcripts (16-mer) can acquire the cap structure in vitro. The capped 
species preserved the α- and β-phosphates of the transcript in the triphosphate linkage. 
Because 5’ monophosphorylated or triphosphorylated transcripts do not function as cap 
acceptors in the reaction*, it suggests that the diphosphorylated 5’ end status is established 
at the very early stage of transcription. His154 is essential for cap-snatching in vitro and in 
vivo. The model depicted in Fig. 4A postulates that the m7Gp-Gag adduct generated by the 
decapping reaction is an intermediate of m7Gp transfer reaction. 
  Crystallographic studies of the L-A virion have identified a trench on the outer 
surface of Gag that includes His154 (22, 23). L-A transcripts are made inside the virion and 
presumably released to the cytoplasm through one of the pores located at the icosahedral 5-
fold symmetric axes (22). The trenches are positioned in the Gag asymmetric dimer close to 
the 2-fold and 3-fold axes, far from the pores. It is likely that the high concentration of PEG 
4000 required in the reaction increases the local concentration of the 5’ end of the viral 
transcript (or the host mRNA cap donor) in the trench, presumably mimicking the 
cytoplasmic environment overcrowded with macromolecules. The physical separation of 
the cap-snatching site from the transcription site may ensure that not all transcripts are 
capped. If capped transcripts were destined for translation and the non-capped ones for 
encapsidation, then the virus might actively participates in this differentiation process by 
changing the ratio of capping. Our data suggest that only virions actively engaging in 
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polymerization have capping activity*, implying that the two sites are coordinated. 
Previously Masison et al. (24) failed to detect the cap-snatching activity of L-A virus, 
presumably because they did not include PEG in the reaction. The authors found that a ski1 
mutation suppresses the effect of the mutation of His154 on expression of M1 toxin and 
proposed an alternative model, a decoy hypothesis in which L-A virus utilizes cellular 
mRNAs decapped by the virus as a decoy to protect its non-capped transcripts from 
degradation by the XRN1/SKI1 5’-3’ exonuclease (24).  
His154 is located at the tip of a loop (residues 144-163) that is part of the upper rim 
of the trench. Upon ligand binding (m7GDP) the rim moves inwardly and forms a closed 
conformation (23). Guanylyltransferase also contains a trench that can adopt either open or 
closed conformations during the mRNA capping reaction (25, 26). Furthermore, it has been 
noticed that secondary structure elements around the trench of Gag resemble those in 
guanylyltransferase (22). This enzyme forms a Gp-enzyme intermediate with GTP and 
transfers Gp to the diphosphorylated 5’ termini of PolII transcripts to generate a non-
methylated cap structure. Thus, the cap-snatching reaction of L-A (Fig. 4A) resembles that 
of guanylyltransferase. These similarities suggest convergent evolution. In the standard 
capping reaction, guanylyltransferase forms a covalent bond with Gp through Lys but not 
His. However, it has been demonstrated that in the capping reaction of vesicular stomatitis 
virus (VSV), L protein covalently binds the 5’ monophosphorylated pre-mRNA through 
His and transfers the bound pre-mRNA to GDP (27). Members of the Alphavirus-like 
superfamily methylate GTP first, then seem to utilize His to form a phosphoamide bond 
with m7Gp and transfer the m7Gp moiety to the 5’ diphosphate end of a viral transcript 
during the capping reaction (28-30). 
In the trench, Tyr150, Asp152, Tyr452 and Tyr538 are located close to m7GDP, 
suggesting their involvement in cap recognition (23). Mutagenesis studies indicate that 
these residues are crucial for decapping activity. Tyr452 and Tyr538 sandwich m7GDP by a 
potential stacking (23). Cap-binding proteins normally use two aromatic rings of Tyr, Phe 
or Trp in cap recognition to sandwich the m7G moiety (31, 32). Fungal totiviruses closely 
related to L-A share these residues (or similar ones) as well as His154 at comparative 
positions in their coat proteins (Fig. 4b). Decapping activity has also been demonstrated in 
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Gag of L-BC virus (14). Therefore, it is likely that the cap-snatching mechanism of L-A 
virus is widespread among totiviruses of fungi. Standard mRNA capping requires three 
sequential enzymatic reactions. L-A virus, however, obtains these caps from host mRNA, 
thus reducing the burden of encoding its own capping machinery in a small dsRNA genome 
(4.6 kb). Typical of a fungal virus, L-A has no extracellular transmission pathway. This 
further eliminates the necessity to encode proteins for exit and re-entry to a new cell. These 
features have apparently contributed to reduce the viral genome to a single dsRNA 
segment. By contrast, infectious dsRNA viruses (Reoviridae) found in higher eukaryotes 
possess their own capping machinery (33) and have genomes with more than 10 or more 
segments. 
 
MATERIALS AND METHODS 
Preparation of the 5 nt cap donor. Non-labeled 106 nt RNA fragment containing the 
polylinker sequence from Bluescript KS+ vector was made by T7 run-off transcription. The 
cap structure was installed on it using [α-32P] GTP with the aid of mScript mRNA 
production system (Epicentre) following the instructions provided by the manufacturer. The 
5 nt cap donor was generated by digesting it with RNase A (14) and purified through a 15% 
acrylamide gel.  
Cap transfer reaction. The standard cap transfer reaction contained 50 mM Tris HCl pH 
7.5, 5 mM MgCl2, 0.1 mM EDTA, 20 mM NaCl, 5 mM KCl, 0.5 mM each of ATP, CTP, 
GTP and UTP, 20% PEG 4000 and labeled 5 nt cap donor (2-5000 cpm). The reaction was 
started by the addition of L-A or M1 virions and kept at 30 ºC for 1 hour. Phenol-extracted 
products were analyzed on either agarose or acrylamide gels. TLC using PEI cellulose was 
done as described (17). Decapping reaction was done as described (14). 
Immunoprecipitation with anti-cap monoclonal antibody. Freshly-growing cells (109 
cells) were harvested and broken by vortex mixing (15 seconds, 10 times) with glass beads 
in a buffer containing 20 mM Tris HCl, pH 8.0 and 100 mM NaCl. After removing cell 
debris, RNA was extracted with phenol from the supernatant and precipitated with ethanol. 
RNA was incubated for 30 min at 4 ºC with 30 µl of protein G-Sepharose (GE Healthcare) 
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pre-bound to anti-m3G/m7G-cap monoclonal antibody (Synaptic Systems, Germany). RNA 
bound to the Sepharose was extracted, blotted to a nylon membrane and hybridized with an 
L-A-, M1-, or 25S rRNA-specific probe as described previously (34). The L-A and M1 
probes recognize the positive strand sequences of L-A (nt 1323-1786) and M1 (nt 14-500), 
respectively. The 25S rRNA probe recognizes nt 139-608 of 25S rRNA. 
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FIGURE LEGENDS  
Fig. 1. Transfer of m7Gp from cap donor to the 5’ end of viral transcript. (A) Labeled 5 nt 
cap donor was incubated in a transcription reaction mixture with L-A virions (lane 1) or M1 
virions with wild type (WT, lane 2) or mutant (Arg154, lane 3) Gag protein and the full-
sized transcripts were separated in an agarose gel. Ethidium bromide staining and 
autoradiogram of the gel are shown.  λ, lambda−HindIII markers. (B) L-A virions were 
incubated with 5 nt cap donor in a transcription mixture from which CTP and GTP were 
omitted. Transcription was done in the presence of GDP (lane 4) or in its absence (lane 3) 
and the products were analyzed on a 15% acrylamide gel. As mobility markers, GTP (lane 
1), cap donor (lane 2), 16-mer (lane 5) and 17-mer primed with m7GpppG (lane 6) were run 
in parallel. The sequence of the cap donor and the position of 32P (indicated by the asterisk) 
are shown on the left of the panel. Under the panel the 5’ end sequence of L-A transcript is 
shown. The first C appears at position 17. (C) The labeled product (marked by the 
arrowhead in lane 4 of Fig. 1B) was isolated from the gel, treated with the enzymes as 
indicated and analyzed on PEI cellulose with 0.3 M (NH4)2SO4. Cap donor was also 
processed in parallel as control. The mobility of non-labeled nucleotides is indicated on the 
left of the panel. Deduced transfer reaction is shown under the panel along with TAP and 
S1 cleavage sites. (D) 7-methylated and non-methylated cap donors were synthesized in the 
presence and in the absence of S-adenosyl methionine (SAM), respectively, and incubated 
with L-A virions as described in the legend to Fig. 1B. The product (17-mer) was separated 
in a 8 M urea/15% acrylamide gel. 
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Fig. 2. Preservation of 5’ diphosphate of L-A transcript in the triphosphate linkage of the 
capped product during cap-snatching. (A) L-A virions were incubated in a CTP-omitted 
transcription mixture in the presence or absence of methylated or non-methylated cap 
analogue (0.5 mM). Transcription was primed with [α-32P] GTP. BAP-treated or non-
treated products were separated in 8 M urea/15% acrylamide gel. The arrowheads indicate 
BAP-resistant capped transcript (17-mer). (B) BAP-resistant 17-mer (Capped) shown in 
Fig. 2A was isolated from the gel, treated with the enzymes singularly or sequentially as 
indicated and analyzed by TLC using 0.3 M (NH4)2SO4 as solvent. Non-capped transcript 
(16-mer) was also processed in parallel as control. Deduced reaction scheme is drawn under 
the panel along with TAP and S1 cleavage sites. (C) L-A virions were incubated in a GTP- 
and CTP-omitted transcription mixture in the presence or absence of m7GpppG (0.5 mM). 
Transcription was primed with GMP in the presence of [γ-32P] ATP. BAP-treated or non-
treated products were separated in an 8 M urea/15% acrylamide gel. The arrowheads 
indicate BAP-resistant capped transcripts (17-mer). (D) BAP-resistant 17-mer (Capped) 
shown in Fig. 2C was isolated and processed as described in the legend to Fig. 1C except 
that TLC was carried out with 1 M LiCl as solvent. Non-capped transcript (16-mer) was 
also processed in parallel as control. RPP: RNA 5’ polyphosphatase that hydrolyses β− and 
γ−phosphates at the 5’ terminus of RNA. Lane 8: Pi standard. Deduced cap transfer 
reaction with some enzymatic cleavage sites is drawn under the panel. The asterisks show 
the positions of the 32P label.  
Fig. 3. Cap-snatching is essential for viral expression. (A) Decapping activity of Gag to 
form m7Gp-Gag adduct.  L-A virions (lane 1) or M1 virions with wild type (WT, lane 2) or 
mutant (Arg154, lane 3) Gag protein were incubated for decapping with 5 nt cap donor 
labeled at the γ-phosphate with 32P. Then proteins were separated in an SDS-gel and 
detected by Coomassie blue staining (left panel) or by autoradiography (right panel). M; 
protein standards for mobility. (B) Detection of capped viral transcripts in vivo. RNA was 
extracted from cells containing M1 supported by L-A plasmid expressing wild type (WT) 
or mutant Gag (Arg154) or from L-A plasmid-cured cells (-) as control. Capped RNA was 
immunoprecipitated with (Anti-cap) or without (-) anti-cap antibody and hybridized with 
M1 (+) strand-specific (upper panel) or L-A (+) strand-specific (lower panel) probe. As 
control, total RNA was processed in parallel (Total RNA). (C) Killer assays.  
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Fig. 4. (A) Schematic diagram of L-A cap-snatching mechanism. In the middle virion, 
m7Gp-His154 adduct is depicted by the asterisk. It is not known which Gag protein in the 
virion participates in the cap transfer reaction. mRNA decapping and cap transfer may be 
coupled with transcription (see text). (B) Comparison of selected L-A Gag sequences with 
those of other fungal totiviruses. His154 and crucial residues for cap recognition are 
indicated by the arrows. GenBank accession numbers are: L-A (AAA50320.1), TaV1 
(ADQ54105.1), BRVF (YP 001497150.1) and L-BC (NP 042580.1). 
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Figure 2 
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Figure 4 
 
 
Legends to supplementary figures.  
 
Fig. S1. The effect of PEG 4000 on the cap-snatching reaction. L-A virions were incubated 
in a CTP- and GTP- omitted transcription mixture that contained PEG 4000 as indicated in 
the panel and labelled 5 nt cap donor. Transcription was primed with GDP. The products 
were extracted with phenol and analyzed on a 15% acrylamide gel. The autoradiogram of 
the gel is shown. 
Fig. S2. Effect of the size of cap donor on cap-snatching reaction. L-A virions were 
incubated with a 5 nt (lane 1) or 107 nt (lane 2) cap donor (3000 cpm) in a standard 
transcription mixture. L-A transcripts were separated in an agarose gel. Ethidium bromide 
staining (left panel) and autoradiogram (right panel) of the gel are shown. M, Lambda 
HindIII size markers.    
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Fig. S3. M1 transcripts synthesized by virions with an Arg154 mutant Gag have 
diphosphate at their 5’ ends. M1 virions with mutant Gag (Arg154) were incubated in a 
CTP-omitted transcription mixture with [a-32P] GTP as a marker. The 17 nt transcripts were 
purified through an acrylamide gel and the S1-treated or non-treated sample was analyzed 
on PEI cellulose with 0.3 M (NH4)2SO4. In lane 3, BAP-treated transcripts were phenol 
extracted and then digested again with S1. Below the panel is shown the 5’ terminal 
sequence of M1 transcript. The 17-mer synthesized by virions in the absence of CTP 
contains two internal Gs that will be released as GMP upon S1 digestion. The ratio of GDP 
to GMP in lane 2 was 1:2.1. The disappearance of GDP in the BAP-treated sample (lane 3) 
indicates that the nucleotide was derived from the 5’ end of the transcripts. 
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